Cover Image

ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in patients with ovarian cancer: a systematic review and meta-analysis

Abstract Objective To explore the relationship between ERCC1 rs11615 polymorphism and chemosensitivity to platinum drugs in ovarian cancer by the method of meta-analysis. Methods Pubmed, Web of Science, EMBASE, Cochrane Library, China National Knowledge Infrastructure (CNKI), and China Wanfang datab...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yuqiang Zhang (Author), Sufen Cao (Author), Chunyu Zhuang (Author), Jiacheng Chen (Author), Xiaojing Chen (Author), Hong Sun (Author), Shengying Lin (Author), Bailang Lin (Author)
Format:	Book
Published:	BMC, 2021-06-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Association between the ERCC1 polymorphism and platinum-based chemotherapy effectiveness in ovarian cancer: a meta-analysis
by: Ning Tang, et al.
Published: (2017)

<i>ERCC1</i> and <i>ERCC2</i> Polymorphisms Predict the Efficacy and Toxicity of Platinum-Based Chemotherapy in Small Cell Lung Cancer
by: Andrés Barba, et al.
Published: (2024)

The Association of Single-Nucleotide Polymorphism rs13181 in ERCC2 with Risk and Prognosis of Nasopharyngeal Carcinoma in an Endemic Chinese Population
by: Wei Z, et al.
Published: (2021)

Non-Coding RNA Polymorphisms (rs2910164 and rs1333049) Associated With Prognosis of Lung Cancer Under Platinum-Based Chemotherapy
by: Yi-Xin Chen, et al.
Published: (2021)

A newly synthesized platinum-based compound (PBC-II) increases chemosensitivity of HeLa ovarian cancer cells via inhibition of autophagy
by: Moureq Rashed Alotaibi, et al.
Published: (2019)

ERCC1 as a marker of prognosis and sensitivity to platinum-based chemotherapy in patients with stage III-IV non-small cell lung cancer
by: O. P. Kolesnik, et al.
Published: (2020)

The effect of ERCC1 and ERCC2 gene polymorphysims on response to cisplatin based therapy in osteosarcoma patients
by: Hadeel Obiedat, et al.
Published: (2018)

Novel Candidate Single Nucleotide Polymorphisms of ERCC2 Gene that Influence Colorectal Cancer Susceptibility
by: Rand Farhad, et al.
Published: (2024)

Evolving treatment paradigms for platinum-resistant ovarian cancer: An update narrative review
by: Hao Lin, et al.
Published: (2024)

Pretreatment with LCK inhibitors chemosensitizes cisplatin‐resistant endometrioid ovarian tumors
by: Katie K. Crean-Tate, et al.
Published: (2021)

The Effects of WISP1 Polymorphisms on the Prognosis of Lung Cancer Patients with Platinum-Based Chemotherapy
by: He J, et al.
Published: (2021)

Impact of ERCC1 gene polymorphisms on response to cisplatin based therapy in oral squamous cell carcinoma (OSCC) patients
by: M L Avinash Tejasvi, et al.
Published: (2020)

Low ERCC1 expression is a good predictive marker in lung adenocarcinoma patients receiving chemotherapy based on platinum in all TNM stages - a single-center study
by: Marina Piljić Burazer, et al.
Published: (2019)

ERCC3 Gene Associated with Breast Cancer: A Genetic and Bioinformatic Study
by: Xiangyu Chen, et al.
Published: (2024)

Novel ERCC2 variant in trichothiodystrophy infant: the first case report in China
by: Jian-Dong Chen, et al.
Published: (2021)

A nomogram to predict platinum-sensitivity and survival outcome in women with advanced epithelial ovarian cancer
by: Tsung-Hsin Yeh, et al.
Published: (2024)

Association of polymorphic markers of the <i>XRCC1</i>, <i>ERCC5</i>, <i>TP53</i>, <i>CDKN1A1</i> genes with the survival of patients after platinum-based chemotherapy for triple negative breast cancer
by: T. M. Zavarykina, et al.
Published: (2023)

Biomarker for colorectal carcinoma -ERCC1-New kid on the block
by: Nalini Bansal
Published: (2019)

Two Novel Mutations in the ERCC8 Gene in a Patient with Ultraviolet-sensitive Syndrome
by: Yue Li, et al.
Published: (2018)

Genetic Polymorphisms and the Efficacy of Platinum-Based Chemotherapy: Review
by: Afifah NN, et al.
Published: (2020)

Misdiagnosis and Chemotherapy Delaying Reduces the Chemosensitivity of Choriocarcinoma Patient: Analysis of 36 Cases
by: Lin-Jing Yuan, et al.
Published: (2022)

Extending platinum-free interval in partially platinum-sensitive recurrent ovarian cancer by a non-platinum regimen: Its possible clinical significance
by: Yin-Ting Chuang, et al.
Published: (2012)

A Retrospective Observational Study of Anlotinib in Patients with Platinum-Resistant or Platinum-Refractory Epithelial Ovarian Cancer
by: Cui Q, et al.
Published: (2021)

ERCC1 and XRCC1 as biomarkers for lung and head and neck cancer
by: Vaezi A, et al.
Published: (2011)

A Novel Mutation in ERCC8 Gene Causing Cockayne Syndrome
by: Maryam Taghdiri, et al.
Published: (2017)

The association between TIPARP gene polymorphisms rs2665390 and ovarian cancer susceptibility
by: Maryam vahidi, et al.
Published: (2023)

Methylenetetrahydrofolate Reductase Gene rs1801133 and rs1801131 Polymorphisms and Essential Hypertension Risk: A Comprehensive Analysis
by: Yingchao Fan, et al.
Published: (2022)

Genetic polymorphisms and platinum-induced hematological toxicity: a systematic review
by: Yi Zheng, et al.
Published: (2024)

In vitro and in vivo evaluation of didymin cyclodextrin inclusion complexes: characterization and chemosensitization activity
by: Qing Yao, et al.
Published: (2020)

Serum Cystatin C as a predictor of acute kidney injury in neonates: a meta-analysis
by: Hui Yang, et al.
Published: (2022)

A risk model of gene signatures for predicting platinum response and survival in ovarian cancer
by: Siyu Chen, et al.
Published: (2022)

The leadership of topotecan in the treatment of recurrent platinum-resistant ovarian cancer
by: K. E. Borisov
Published: (2014)

ADC: a deadly killer of platinum resistant ovarian cancer
by: Xu Cheng, et al.
Published: (2024)

The rs2275913 polymorphism of the interleukin-17A gene is associated with the risk of ovarian endometriosis
by: Zhen Xie, et al.
Published: (2023)

Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer
by: Zhongmian Pan, et al.
Published: (2023)

Evaluation of Pegylated Liposomal Doxorubicin in the Treatment Of Both Platinum- and Paclitaxel-Refractory Epithelial Ovarian Cancer
by: Hao Lin, et al.
Published: (2004)

A Recurrent Platinum Refractory Ovarian Cancer Patient With a Partial Response After RRx-001 Resensitization to Platinum Doublet
by: Hope Cottrill MD, et al.
Published: (2018)

The Association Between Genetic Polymorphisms of Transporter Genes and Prognosis of Platinum-Based Chemotherapy in Lung Cancer Patients
by: He J, et al.
Published: (2022)

Expression patterns and prognostic significances of RRM1 and ERCC1 in pancreatic carcinoma and cholangiocarcinoma
by: Khushbu Khetan, et al.
Published: (2021)

Gene polymorphism and prediction of toxicity to platinum‐based chemotherapy in patients with gynecologic cancer
by: Xuan Huang, et al.
Published: (2023)